The ultimate goal would be discover new variants in new genes in all those patients mutation-negative for genes already found mutated, as was demonstrated for ALPK1 and ROSAH syndrome. The gene discussed is ALPK1; the disease is retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome.